pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
718
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
AGT103-T
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Addimmune
0
catalysts
Phase 1
ALX-1
Bronchiectasis
Parathyroid hormone/parathyroid hormone-related peptide receptor
Vast Therapeutics Inc
0
catalysts
Phase 1
AOPNS-042
Unspecified Infectious Diseases
Aodh Lifesciences Pvt Ltd
0
catalysts
← prev
page 6 of 24
next →
131
Pain
89
Neurology
1
Preclinical
APC-247
Gram-Negative Bacterial Infections
AdjuTec Pharma AS
0
catalysts
Phase 2
APH-0812
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Aphios Corp
0
catalysts
Phase 2
APPA-02
Resistant Pseudomonas aeruginosa Infections
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 2
APSA-02
Bacteremia
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 2
ARCT-165
Coronavirus Disease 2019 (COVID-19)
Seqirus Ltd
0
catalysts
Phase 1
ARCT-2304
Influenza A Virus, H5N1 Subtype Infections
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Preclinical
ASD-006
Atherosclerosis
Asdera LLC
0
catalysts
Preclinical
ATI-1701
Tularaemia
Appili Therapeutics Inc
0
catalysts
Phase 2
AV-1
Dengue Fever
Glutamate [NMDA] receptor
AbViro LLC
0
catalysts
Phase 2
AZD-5148
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
AZD-7760
Staphylococcus aureus Infections
$AZN
ASTRAZENECA PLC
0
catalysts
Marketed
Abrysvo
Respiratory Syncytial Virus (RSV) Infections
$PFE
PFIZER INC
0
catalysts
Phase 2
Adipose Tissue Derived Mesenchymal Stem Cells
Coronavirus Disease 2019 (COVID-19)
CellTex Therapeutics Corp
0
catalysts
Preclinical
Alpha 1
Tuberculosis
Asia Scientific Global
0
catalysts
Preclinical
Anti-CSP Monoclonal Antibody
Malaria
PATH
0
catalysts
Marketed
Arexvy
Respiratory Syncytial Virus (RSV) Infections
GlaxoSmithKline Biopharmaceuticals inc
0
catalysts
Phase 2
AstroStem-V
Coronavirus Disease 2019 (COVID-19) Pneumonia
Nature Cell Co., Ltd.
0
catalysts
Marketed
Augmentin
Augmentin ((amoxicillin + clavulanate potassium))
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
NeoPharma Inc
0
catalysts
Preclinical
BAL-200
Anthrax
iNtRON Biotechnology Inc
0
catalysts
Preclinical
BB-IO
Unspecified Infectious Diseases
BroadenBio Co Ltd
0
catalysts
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
0
catalysts
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
0
catalysts
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
0
catalysts
Phase 2
BPZE1 vaccine
Pertussis (Whooping Cough)
ILiAD Biotechnologies LLC
0
catalysts
Phase 1
BRII-732
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Brii Biosciences Ltd
0
catalysts
Preclinical
BWV-302
Malaria
$ONCO
Onconetix, Inc.
0
catalysts
Phase 2
BX-211
Diabetic Foot Infection (DFI)
$PHGE
BiomX Inc.
0
catalysts
